CGCharles William Given

Charles William Given

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charles William Given has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Family functioning among adolescents with developmental disabilities utilizing augmentative and alternative communication

    by Patricia West, Lorraine Robbins, Sarah N. Douglas, Charles Given, Barry DeCicco, Dola Pathak, Gwen Wyatt

    Family involvement is critical for adolescents with developmental disabilities and complex communication needs; especially for adolescents requiring augmentative and alternative communication (AAC). This study aimed to examine the relationship between parental and adolescent characteristics and family functioning across three groups of families based on the frequency of adolescents' use of AAC. This cross-sectional study included families of adolescents aged 13 to 18 years with autism spectrum disorder (ASD) and/or Down syndrome (DS) who use AAC. A family consisted of at least one parent or guardian and an adolescent. Families enrolled in the study through online recruitment registries, support organizations, and social media. In total, 227 families (parent as proxy) completed an online survey, which included the Family Impact of Assistive Technology Scale for AAC (FIATS-ACC) measure. The FIATS-ACC scores across the three usage groups (high, moderate, low) were compared. Parental/adolescent characteristics associated with family functioning included parental employment and education, parent age, adolescent communication function, and type of AAC device. Communication function emerged as the only predictor of family functioning. The mean unadjusted family functioning score for the high-usage group was significantly higher than both the low- and moderate-usage groups. Findings provide insights into at-risk families and imply the need for individualized family interventions to optimize outcomes.


  • A sequential multiple assignment randomized trial of symptom management for cancer survivors during treatment and their informal caregivers

    by Terry Badger, Chris Segrin, Tracy E. Crane, Pavani Chalasani, Waqas Arslan, Mary Hadeed, Charles W. Given, Alla Sikorskii

    Context Many cancer survivors and their informal caregivers experience multiple symptoms during the survivor’s treatment. Objective Test relative effectiveness and optimal sequencing of two evidence-based interventions for symptom management. Methods In this sequential multiple assignment randomized trial (SMART), survivors of solid tumors with elevated depression or anxiety and their caregivers as dyads were initially randomized after baseline assessment in a 3:1 ratio to the Symptom Management and Survivorship Handbook (SMSH, N = 277 dyads) intervention or SMSH plus 8 weeks of telephone interpersonal counseling (TIPC, N = 97 dyads). After 4 weeks, survivors who were not responding (no improvement or worsening score on depression and/or anxiety item) to SMSH only and their caregivers were re-randomized to continue with SMSH alone (N = 44 dyads) to give it more time or to SMSH + TIPC (N = 44 dyads). Mixed effects and generalized linear models compared severity of depression, anxiety, and a summed index of 16 other symptoms over weeks 1–13 and week 17 between randomized groups and among three dynamic treatment regimes (DTRs). Dyads received SMSH only for 12 weeks (DTR1); SMSH for 12 weeks with 8 weeks of TIPC added from week 1 (DTR2); and SMSH for 4 weeks followed by the combined SMSH + TIPC for 8 weeks if no response at 4 weeks (DTR3). Results Survivors randomized initially to SMSH alone had significantly lower anxiety over weeks 1–13 compared to those randomized to the combined SMSH + TIPC. In comparing DTRs, survivor’s anxiety was significantly lower at week 13 for DTR1 compared to DTR2 with no other main effects for survivors or caregivers. Exploratory moderation analyses indicated a potential benefit of adding TIPC for caregivers of non-responders with elevated baseline symptoms. Conclusion SMSH + TIPC did not result in better symptom outcomes at week 17 than SMSH alone. Lower intensity SMSH may improve depression and anxiety symptoms for most survivors and their caregivers. Trial registration Clinicaltrails.gov ID number, NCT03743415; approved and posted on 11/16/2018.


  • Predictors of persistence of post-chemotherapy symptoms among survivors of solid tumor cancers

    by Alla Sikorskii, Terry Badger, Chris Segrin, Tracy E. Crane, Nathan Cunicelli, Pavani Chalasani, Waqas Arslan, Charles Given

    Context Late or residual symptoms diminish quality of life for many cancer survivors after completion of treatment. Objectives Examine risk factors associated with persisting symptom burden after chemotherapy and the lack of symptom improvement over time. Methods Survivors who completed curative-intent chemotherapy within two years for solid tumors were enrolled into a symptom management trial. There were 375 survivors with two or more comorbid conditions or one comorbid condition and elevated depressive symptoms (pre-defined risk factors in the trial design) who received interventions and 71 survivors without these risk factors who did not receive interventions. For all survivors, symptoms were assessed at intake, 4, and 13 weeks and categorized as mild, moderate, or severe based on the interference with daily life. The probabilities of moderate or severe symptoms and symptom improvement were analyzed using generalized mixed-effects models in relation to comorbidity, depressive symptoms, age, sex, race/ethnicity, employment, time since chemotherapy completion, and physical function. Multiple symptoms were treated as nested within the survivor. Results Moderate or severe symptoms at baseline and the lack of improvement over time were associated with younger age and lower physical function over and above a greater number of comorbidities and elevated severity of depressive symptoms. Conclusion Risk factors identified in this research (younger age, lower physical function, greater comorbidity, and higher depressive symptoms) can be used to allocate resources for post-treatment symptom management for cancer survivors in order to relieve symptoms that do not necessarily resolve with time.


  • Perceptions of families with adolescents utilizing augmentative and alternative communication technology: A qualitative approach

    by Patricia West, Emily J. Jensen, Sarah N. Douglas, Gwen Wyatt, Lorraine Robbins, Charles Given


  • A literature review of coping strategies and health-related quality of life among patients with heart failure

    by Mohammed Owayrif Alanazi, Charles W Given, Pallav Deka, Rebecca Lehto, Gwen Wyatt

    Aims: To identify and provide clarity on factors that influence coping and the type of coping strategies used by patients with heart failure (HF) to improve health-related quality of life (HRQoL).Methods and results: The Arksey and O’Malley template framed this scoping review guided by the stress and coping model. Five databases were explored: PubMed, Web of Science, Cochrane, CINAHL, and PsycINFO. Keywords included HF, quality of life, coping, and influencing factors. Eligibility criteria involved patients with HF, reported on coping strategies and HRQoL, and published in English. Thirty-five studies were included (4 randomized controlled trials, 27 cross-sectional, and 4 qualitative/mixed methods). Active emotional coping (e.g. acceptance) and problem-focused (e.g. seeking social support) coping strategies were linked to better HRQoL, while avoidant emotional coping (e.g. denial) was linked to worse HRQoL. In the presence of the stressor of HF severity, key factors that influenced the types of the coping strategy included sex, age, social support, income, education, spiritual beliefs, and illness duration. However, the evidence on the effectiveness of the type of coping on HRQoL remains inadequate due to the majority of studies being cross-sectional.Conclusion: Problem-focused and active emotional coping strategies are associated with improved HRQoL. However, their effect is inconclusive due to the lack of experimental studies. Additional predictive studies will enhance the understanding of coping among HF patients.


  • Use of scheduled and unscheduled health services by cancer survivors and their caregivers

    by Alla Sikorskii, Chris Segrin, Tracy E. Crane, Pavani Chalasani, Waqas Arslan, Jessica Rainbow, Mary Hadeed, Charles Given, Terry A. Badger

    Purpose The purpose was to determine predictors of scheduled and unscheduled health services use by cancer survivors undergoing treatment and their informal caregivers. Methods English- or Spanish-speaking adult cancer survivors undergoing chemotherapy or targeted therapy for a solid tumor cancer identified a caregiver (N = 380 dyads). Health services use over 2 months was self-reported by survivors and caregivers. Logistic regression models were used to relate the likelihood of service use (hospitalizations, emergency department [ED] or urgent care visits, primary care, specialty care) to social determinants of health (age, sex, ethnicity, level of education, availability of health insurance), and number of comorbid conditions. Co-habitation with the other member of the dyad and other member’s health services use were considered as additional explanatory variables. Results Number of comorbid conditions was predictive of the likelihood of scheduled health services use, both primary care and specialty care among caregivers, and primary care among survivors. Greater probability of specialty care use was associated with a higher level of education among survivors. Younger age and availability of health insurance were associated with greater unscheduled health services use (hospitalizations among survivors and urgent care or ED visits among caregivers). Unscheduled health services use of one member of the dyad was predictive of use by the other. Conclusions These findings inform efforts to optimize health care use by encouraging greater use of scheduled and less use of unscheduled health services. These educational efforts need to be directed especially at younger survivors and caregivers.


  • Open Access

    Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes

    by Alla Sikorskii, Charles W Given, Barbara A Given, Asish Banik, John C Krauss

    Background: Self-management of symptoms related to cancer and its treatment is important for maintaining treatment regimens and improving outcomes. Purpose: To determine factors associated with engagement in a symptom self-management intervention among patients initiating oral anticancer treatment. Methods: This secondary analysis included 127 patients randomized to the medication adherence reminder and symptom management intervention in a recently completed trial. Patients were recruited from six Comprehensive Cancer Centers, interviewed at intake, and mailed a Symptom Management Toolkit (Toolkit) with self-care management strategies for 18 symptoms. During eight automated telephone weekly calls, patients were asked to use the Toolkit to manage elevated symptoms. Toolkit use and symptoms were tracked weekly, and generalized linear mixed-effects models were used to determine factors predictive of Toolkit use. General linear modeling was used to relate the Toolkit use during intervention to postintervention symptom severity. Results: Better cognitive function at intake into the trial and higher symptom burden were predictive of the patients’ initial decision to try the Toolkit during Week 1. In subsequent weeks, Toolkit use in the previous week and worsening of symptoms were associated with greater odds of Toolkit use. The extent of Toolkit use modified the relationship between intake and 8 week symptom severity: among patients with higher levels of severity at intake, use of the Toolkit conferred greater benefit at 8 weeks. Conclusions: Patients make realistic decisions regarding when to use a self-directed approach to self-management and are likely to use strategies when their symptoms are higher and to forego use once symptoms subside. Clinical Trial Registration: NCT02043184.


  • Introduction

    by Barbara A. Given, Charles W. Given, Dorothy Luckie